Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the
Efficacy, Safety and Pharmacokinetics of MG in Patients With alcoholic Fatty Liver Disease
and Alcoholic Hepatitis.